Novo Nordisk: Why Is the Stock Falling Over 20% Today?
Novo Nordisk (NYSE:) shares are experiencing a dramatic selloff in premarket buying and selling, plunging over 20% after the Danish ...
Tag: Novo
Obesity drug maker Novo Nordisk ousts CEO as competition weighs
Wegovy-maker Novo Nordisk mentioned on Friday its CEO Lars Fruergaard Jorgensen will step down over issues the corporate is dropping ...
Get the latest financial news, expert analysis, and in-depth reports from The Financial Observer. Stay ahead in the world of finance with up-to-date trends, market insights, and more.